Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent Wallner

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
American Journal of Clinical Oncology|April 1, 2008
There is a wide range of predictive dosimetric factors for I-125 and pd-103 prostate brachytherapyAndrew Herstein, Kent Wallner, Gregory Merrick, et al.
Brachytherapy|April 6, 2004
Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapyJacques Corriveau, Kent Wallner, Gregory Merrick, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2003
The effect of supplemental beam radiation on prostate brachytherapy-related morbidity: morbidity outcomes from two prospective randomized multicenter trialsMaged Ghaly, Kent Wallner, Gregory Merrick, et al.
Brachytherapy|January 6, 2026
Randomized trial of dose de-escalation in low-risk prostate cancer patients implanted with Pd-103Martin King, Grgur Mirić, Mutlay Sayan, et al.
Prostate Cancer and Prostatic Diseases|September 11, 2025
Brachytherapy monotherapy for favorable and select unfavorable intermediate risk prostate cancerMartin King, Grgur Mirić, Robert Galbreath, et al.
IEEE Transactions on Medical Imaging|December 16, 2006
Semiautomatic 3-D prostate segmentation from TRUS images using spherical harmonicsIsmail B Tutar, Sayan D Pathak, Lixin Gong, et al.
American Journal of Clinical Oncology|December 20, 2007
The prognostic significance of Gleason pattern 5 in prostate cancer patients treated with Pd-103 brachytherapyHiroki Mitsuyama, Kent Wallner, Gregory Merrick, et al.
Medical Physics|November 19, 2025
Comparison of integrated biological effectiveness of eye plaques with <sup>125</sup>I and <sup>103</sup>Pd photon sources using equivalent uniform RBE-weighted doseYulun He, Kent Wallner, Jonathan J Chen, et al.
Medical Physics|January 7, 2003
Modification of prostate implants based on postimplant treatment margin assessmentAmy Mueller, Kent Wallner, Gregory Merrick, et al.
Cancer Journal (Sudbury, Mass.)|June 23, 2005
Extraprostatic seed placement and its effect on seed lossElena Nedea, Kent Wallner, Daniel Reed, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
American Journal of Clinical Oncology|April 1, 2008
There is a wide range of predictive dosimetric factors for I-125 and pd-103 prostate brachytherapyAndrew Herstein, Kent Wallner, Gregory Merrick, et al.
Brachytherapy|April 6, 2004
Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapyJacques Corriveau, Kent Wallner, Gregory Merrick, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2003
The effect of supplemental beam radiation on prostate brachytherapy-related morbidity: morbidity outcomes from two prospective randomized multicenter trialsMaged Ghaly, Kent Wallner, Gregory Merrick, et al.
Brachytherapy|January 6, 2026
Randomized trial of dose de-escalation in low-risk prostate cancer patients implanted with Pd-103Martin King, Grgur Mirić, Mutlay Sayan, et al.
Prostate Cancer and Prostatic Diseases|September 11, 2025
Brachytherapy monotherapy for favorable and select unfavorable intermediate risk prostate cancerMartin King, Grgur Mirić, Robert Galbreath, et al.
IEEE Transactions on Medical Imaging|December 16, 2006
Semiautomatic 3-D prostate segmentation from TRUS images using spherical harmonicsIsmail B Tutar, Sayan D Pathak, Lixin Gong, et al.
American Journal of Clinical Oncology|December 20, 2007
The prognostic significance of Gleason pattern 5 in prostate cancer patients treated with Pd-103 brachytherapyHiroki Mitsuyama, Kent Wallner, Gregory Merrick, et al.
Medical Physics|November 19, 2025
Comparison of integrated biological effectiveness of eye plaques with <sup>125</sup>I and <sup>103</sup>Pd photon sources using equivalent uniform RBE-weighted doseYulun He, Kent Wallner, Jonathan J Chen, et al.
Medical Physics|January 7, 2003
Modification of prostate implants based on postimplant treatment margin assessmentAmy Mueller, Kent Wallner, Gregory Merrick, et al.
Cancer Journal (Sudbury, Mass.)|June 23, 2005
Extraprostatic seed placement and its effect on seed lossElena Nedea, Kent Wallner, Daniel Reed, et al.
Pageof 8